Amicus Therapeutics
   
contact us sitemap
 
 

Insider Stock Transactions

Date Name Title Type Shares Traded Price Range
Mar 2, 2010 crowley john f Officer Buy 11,898 3.69
Nov 4, 2009 barer sol j Director Buy 20,000 4.13
Oct 1, 2009 dentzer james e Officer Disposition (Non Open Market) 220 8.75
Sep 1, 2009 dentzer james e Officer Disposition (Non Open Market) 220 9.83
Aug 12, 2009 crowley john f Officer Disposition (Non Open Market) 10,000 n/a
Aug 1, 2009 dentzer james e Officer Disposition (Non Open Market) 220 11.39
Jul 16, 2009 crowley john f Officer Automatic Sell 3,500 10.29
Jul 15, 2009 crowley john f Officer Automatic Sell 6,500 10.69
Jul 14, 2009 crowley john f Officer Automatic Sell 4,748 10.28
Jul 13, 2009 crowley john f Officer Automatic Sell 800 10.09
Jul 10, 2009 crowley john f Officer Automatic Sell 200 10.06
Jul 9, 2009 crowley john f Officer Automatic Sell 1,652 10.24
Jul 8, 2009 crowley john f Officer Automatic Sell 12,900 10.37 - 12.49
Jul 7, 2009 crowley john f Officer Automatic Sell 6,200 11.15 - 11.69
Jul 6, 2009 crowley john f Officer Automatic Sell 13,500 10.42 - 11.59
Jul 1, 2009 dentzer james e Officer Disposition (Non Open Market) 220 11.45
Jun 29, 2009 palling david Officer Automatic Sell 2,500 10.54
Jun 26, 2009 palling david Officer Automatic Sell 7,498 10.00
Jun 1, 2009 dentzer james e Officer Disposition (Non Open Market) 220 6.64
May 1, 2009 dentzer james e Officer Disposition (Non Open Market) 220 8.95
Showing 1-20 of 371 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19  See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics makes no representation or warranty with respect any of to the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.